Targeting EBV Encoded Viral Kinases with GCV, AZT, Rituximab and Dexamethasone (GARD) Results in Durable Responses in Patients with CNS Lymphoproliferative Disease

Introduction: Epstein-Barr virus positive (EBV+) central nervous system lymphoproliferative diseases (CNS-LPD) are aggressive clinical conditions with poor prognosis. EBV+ CNS-LPD often occurs in the setting of immune suppression and comorbidities (solid organ transplant, autoimmunity). Treatment wi...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Blood 2023-11, Vol.142 (Supplement 1), p.4476-4476
Hauptverfasser:	Klimaszewski, Haley L., Weigel, Christoph, Addissie, Selamawit, Schlotter, Sarah, Fode, Tounkara, Dugan, James P., Haverkos, Bradley M., Villagomez, Lynda, Lustberg, Mark, Porcu, Pierluigi, Voorhees, Timothy, Caligiuri, Michael A, Oakes, Christopher C., Bumgardner, Ginny, Baiocchi, Robert
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!